MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
May 19, 2021 17:05 ET
|
MacroGenics, Inc.
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have ≥ 50% PSA reduction;...
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
April 10, 2021 08:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, April 10, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Sorrento Announces First Patient Treated in Phase IB AL Amyloidosis Trial with STI-6129, an Anti-CD38 Antibody-Drug Conjugate
March 18, 2021 09:00 ET
|
Sorrento Therapeutics, Inc.
STI-6129 is an antibody-drug conjugate (ADC) composed of a fully human monoclonal anti-CD38 antibody covalently bound by a proprietary chemical linker to a duostatin tubulin inhibitor.Amyloid Light...
Growing at an annualized rate of over 12%, the ADC contract manufacturing market is estimated to reach close to USD 3 Billion by 2030, claims Roots Analysis
February 04, 2021 11:00 ET
|
Roots Analysis
London, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “ADC Contract Manufacturing Market (4th Edition), 2020-2030” report to its list of offerings. Manufacturing of...
Kemp Wins IT Optimisation Product of the Year
October 13, 2020 09:00 ET
|
Kemp
NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Kemp, the leader in powering always-on application experience [AX], today announced it has won “IT Optimisation Product of the Year” as part of the annual...
MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics
September 23, 2020 07:15 ET
|
MacroGenics, Inc.
Manuscript describes preclinical development of MGC018Phase 1 dose expansion trial evaluating MGC018 in patients with mCRPC, TNBC and NSCLC is currently recruiting patients ROCKVILLE, MD,...
Software Load Balancers Secure First Responder Electronic Patient Care Reporting
August 27, 2020 09:00 ET
|
Kemp
ImageTrend taps Kemp for healthcare compliance while keeping on-scene patient data flowing during COVID-19 and beyond NEW YORK, Aug. 27, 2020 (GLOBE NEWSWIRE) -- When it comes to electronic patient...
Kemp Optimizes Application Experience for Citrix Virtual Apps and Desktops
July 22, 2020 09:00 ET
|
Kemp
NEW YORK, July 22, 2020 (GLOBE NEWSWIRE) -- Kemp, the leader in powering always-on application experience [AX], today announced that its LoadMaster load balancers now provide templated, turn-key...
Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12 (alphalex™-exatecan), a Novel Treatment for Solid Tumors
July 07, 2020 07:00 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., July 07, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...
Kemp Intros Next Generation Ultra High Capacity X Series Load Balancer for 300M Connection Deployments
May 28, 2020 08:00 ET
|
Kemp
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- Kemp, the leader in powering always-on application experience [AX], today released the LoadMaster X40M load balancer/application delivery controller (ADC)...